Abstract. Few studies have investigated the changes of Th1-and Th2-type cytokines in pulmonary embolism (PE) patients. In this study, the gene expression of interleukins and the balance of Th1-and Th2-type cytokines in the peripheral blood mononuclear cells (PBMCs) of PE patients and controls were investigated. A total of 20 PE patients and 20 genderand age-matched controls were included in the study. Human cDNA microarray analysis was used to detect the differences in cytokine gene expression between the two groups and a random variance model corrected t-test was used to analyze the statistical data. In comparison with the controls, 12 genes were found to be downregulated, specifically IL1A, IL9, IL17B, IL19, IL23A, IL25 (P<0.05), IL2, IL3, IL13, IL22, IL24 and IL31 (P<0.01), and 2 genes were found to be upregulated, specifically IL10 and IL28A, in the PE patients. The expression levels of IFN-γ and IL2 mRNA in the PE patients were significantly lower than those in the control group (P<0.01), while the IL20 mRNA expression levels were significantly upregulated (P<0.01). We conclude that there are significant differences in interleukin gene expression between the PE patients and the control group. A shift of the Th1/Th2 balance comprising enhanced Th2 activity and reduced Th1 activity in the PE patients is also demonstrated.
Introduction
Venous thromboembolism (VTE) includes PE thrombosis (DVT) and pulmonary embolism (PE) (1) and PE comprises acute pulmonary embolism (APE) and chronic thromboembolic pulmonary hypertension (CTEPH). VTE may be acquired or inherited, but is most commonly acquired, and its prophylaxis is not satisfactory. PE, with its high incidence, high mortality and high rates of missed diagnosis and misdiagnosis, has become a major health problem worldwide (2) . The immune system comprises innate and adaptive defenses and the latter involves cell-mediated and humoral immune components. We have previously reported that patients with CTEPH had reduced T cell-mediated immune function (3) and we have also demonstrated that VTE is a systemic disease, the incidence of which is related to viral infection (4) . Interleukins play an important role in immune regulation. Th1 cells, which produce IL2 and IFN-γ, chiefly mediate cellular immune responses, while Th2 cells, which secrete IL4, IL6 and IL10, chiefly mediate humoral immune responses (5) . In the current study, human cDNA microarray analysis was used to detect the expression of interleukin and IFN-γ genes in PBMCs and changes in the acquired immune functions of PE patients and the control group.
Patients and methods

Patients.
A total of 20 patients with PE were recruited from the Tongji Hospital of Tongji University from 2007 to 2008. A diagnosis of PE required any two of the following three criteria: i) selectivity pulmonary angiography shows pulmonary artery obstruction or filling defect; ii) lung ventilation/perfusion scan shows single or multiple blood perfusion defect, normal or abnormal ventilation and V/Q does not match; iii) clinical diagnosis: risk factors for PE are present and other cardiovascular diseases may be excluded by clinical performance, electrocardiogram and chest film; arterial blood gas analysis suggests hypoxemia and hypocapnia; and D-dimer detection, echocardiography and/or chest computed tomography support PE diagnosis. We selected 20 patients admitted to our Department of Cardiology over the same time period to act as controls. The patients were divided into two groups: i) a PE patient group comprising 20 patients (11 males and 9 females) with a mean age of 70±14 (44-89) years, including 3 cases of CTEPH; and ii) a control group comprising 20 patients (11 males and 9 females) without PE, DVT, arterial thrombosis or congenital coagulation abnormality, with a mean age of 72±14 (44-91) years, which were matched by gender and age with the PE group. No statistically significant differences were observed between the ages of the two groups (P>0.05). The clinical trial was approved by the Ethics Committee of Tongji University and all participants provided their written informed consent. Total RNA isolation. Peripheral blood samples (5 ml) anticoagulated with EDTA were drawn from the patients suspected of having PE immediately after admittance to the hospital and from the patients without PE. Mononuclear cells were obtained through density gradient centrifugation with Ficoll solution and the remaining red blood cells were destroyed with erythrocyte lysis buffer (Qiagen, Hilden, Germany). Total mononuclear cell RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA, USA) and purified using a Qiagen RNeasy column (Qiagen) according to the manufacturer's instructions. The isolated total RNA was identified and quantified using a Nanodrop ND-1000 spectrophotometer (Nanodrop Technology, Cambridge, UK).
Detection of gene expression. Total RNA (~1 µg) was reversetranscribed into double-stranded cDNA. After purification, in vitro amplification was performed using the Agilent low RNA input linear amplification kit (Agilent Technologies) and modified UTP [aaUTP, 5-(3-aminoally1)-UTP] was used to replace UTP. The integrated aaUTP may interact with Cy3 NHS ester to form fluorescent products which are then used for hybridization. The integration rate of fluorescence was determined using the Nanodrop ND-1000 spectrophotometer. A hybridization mixture was prepared using an Agilent oligonucleotide microarray In situ Hybridization Plus kit. The fluorescent products (~750 ng) were fragmented at 60˚C and hybridization was conducted on Human Whole-Genome 60-mer oligo chips (G4112F, Agilent Technologies) at 60˚C for 17 h at 10 rpm. After hybridization, the chips were washed with Agilent Gene Expression wash buffer according to the manufacturer's instructions. Original signals were obtained with Agilent scanner and Feature Extraction software. The standardization of the original signals was carried out by the RMA standardized method and standardized signal values were used for the screening of differentially expressed genes.
RT-PCR.
Three genes, CCL3L3, ZNF683 and LBA1, were selected from the microarray and their expression was confirmed by RT-PCR. From the differentially expressed genes, 3 genes were randomly selected and subjected to RT-PCR together with the housekeeping gene (GAPDH). The relative expression levels were expressed as the expression levels of the target genes normalized to the expression level of GAPDH ). Melting curve and 2 -∆∆Ct methods were used to compare the differences in the expression levels between the control and PE groups. The results from the RT-PCR procedure were consistent with those from the microarray analysis.
Statistical analysis. Agilent Feature Extraction software was used to collect original data from the microarray which was then analyzed using the robust multichip average (RMA) algorithm. Gene intensity data for the PE and control groups were compared using the random variance model corrected t-test. Differentially expressed genes were identified from whole genomes. P<0.05 was considered to indicate a statistically significant result.
Results
Differential expression of interleukins.
A total of 37 interleukin genes were detected (Table I ). In comparison with the control, the expression levels of 12 genes were downregulated Tables II and III) .
Discussion
Human cDNA microarray analysis was used to detect the expression of interleukin and IFN-γ genes in PBMCs from the The immune system needs to maintain a balance since imbalance will cause it to over-or under-respond. In the adaptive immune system, cell-mediated immunity and humoral immunity also require balance and this is primarily regulated by Th1 and Th2 cytokines.
In the current study, the mRNA expression levels of the Th1 cytokines IFN-γ and IL2 in the PE patients were significantly downregulated (P<0.01), while the mRNA expression levels of the Th2 cytokine IL10 were significantly upregulated, suggesting reduced Th1 activity and enhanced Th2 activity. The shift of the Th1/Th2 balance indicates a disorder of the immunological regulation function. Downing et al have reported elevated IL10 in the vein wall during venous thrombosis (7) and elevated levels of IL6 have been reported in DVT (8) . These studies show increased levels of Th2 cytokines and enhancement of the humoral immune response in VTE, which supports our results.
We have previously reported that the numbers of CD3 + and CD8 + T cells in patients with CTEPH are significantly reduced (3) and that virus-like structures were synthesized and released in a patient with pulmonary hypertension (9) . We have also previously found that T cell and NK cell immunity function-associated genes were downregulated in patients with PE (10) , and that CD3 + CD8 + T cell immunity is dysfunctional in acute PE patients (11) . These studies demonstrate a compromised cell-mediated immunity. In the current study, a shift of the Th1/Th2 balance along with enhanced Th2 activity in PE patients was demonstrated, indicating that cell-mediated immunity was compromised. The result is consistent with the reduced T cell function reported in the aforementioned studies Our findings demonstrate the association between symptomatic VTE and adaptive immunity. The imbalance of Th1/Th2 manifests as reduced cell-mediated immunity and increased humoral immunity, which indicates that the immune system plays a role in the regulation of the immune balance. The upregulation of humoral immunity may be the result of the regulation of the immune system to establish a new balance. The immune system comprises two major parts, the innate immune system and the adaptive immune system, which defend against invading organisms. The function of T cells and NK cells in cell-mediated immunity is mainly antiviral, while the principal function of B cells in humoral immunity is the generation of antibodies. When there is a disturbance in immune function, the ratio of Th1/Th2 shifts and the body is susceptible to infection. Infection is a risk factor for VTE (12) , therefore individuals who are vulnerable to infection may be susceptible to VTE. 
